-+ 0.00%
-+ 0.00%
-+ 0.00%

Estrella Immunopharma Appoints Hong Zhang As Chairperson And Board Member Following Dosing Of First Patient In Phase I/II Clinical Trial For EB103 T-Cell Therapy

Benzinga·08/14/2024 16:01:36
Listen to the news

Board Expands From Five To Six Directors, CEO Dr. Cheng Liu Continues As Director